The US government banned the use of Chinese AI startup DeepSeek's technology in federal agencies, citing security risks, while DeepSeek responded by open-sourcing its DeepInfer inference engine. Otter.ai secured $320 million in funding to advance its AI meeting assistant and expand internationally. Additionally, OpenAI acquired Orchestra Bio to enhance its AI capabilities in drug development and life sciences research. These developments highlight ongoing tensions in AI geopolitics alongside significant investments in enterprise AI and biotech applications.
Digests
Catch up on the AI topics that gained momentum, one day, week or month at a time. Filter by date, period or keyword, or search the text.
1–1 of 1 digest